Coherus Oncology Inc (CHRS)

SBC to Revenue

34.72%

Quarterly · Period ending:

CHRS logo

CHRS SBC to Revenue

Latest reported34.72%
CHRS Quarterly SBC/Revenue (174.31% → 34.72%)
High-resolution chart · PNG

CHRS sbc to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc SBC to Revenue — Quarterly
Period endingSBC to Revenue
34.7243%
19.3745%
84.6643%
29.2887%
52.8672%
70.6935%
11.7908%
9.7041%
0%
317.1144%
11.798%
13.3475%
17.1623%
37.8653%
25.8555%
27.0386%
23.0254%
21.4239%
0%
14.471%
13.2298%
20.3338%
8.9414%
8.1963%
6.9468%
0%
5.8713%
7.9089%
9.5789%
25.5917%
0%
0%
0%
0%
0%
0%
650.3226%
4,850.9317%
910.545%
5.0788%
43.702%
43.0294%
50.7354%
66.1923%
67.3027%
37.5559%
58.925%
17.0384%
24.3706%
91.5184%
25.2435%
197.2332%
1,429.3886%
174.3083%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.